The Syngene Advantage: Accelerating Progress Through Integrated Technology Transfer

At Syngene, technology transfer is a seamless, cross-site collaboration, accelerating your journey from concept to commercialization. This video showcases the synergy between our Bangalore (BSEZ) and Mangalore (MSEZ) campuses, driven by robust systems and deep expertise. Our facilities are built for uncompromising quality, proudly GMP certified, 21 CFR compliant, and USFDA approved, ensuring global standards are met at every step. From advanced process and analytical research to meticulous engineering and safety protocols, we emphasize alignment, transparency, and cost-effective execution. Discover how Syngene’s commitment to scalable, economical, and safe processes, supported by our dedicated teams, translates into reliable outcomes. Partner with us for long-term manufacturing and supply solutions, backed by scientific alignment and operational synergy that truly puts science to work for your success.

Author

Latest Blogs

Why CDMO Outsourcing is Moving Earlier in Biologics Development

Infographic showing the shift from traditional pharma outsourcing based on cost and capacity to a new-age CRDMO model focused on scientific depth, speed, supply-chain resilience, integration, and development flexibility.

The New-Age CRDMO: Rethinking Drug Development Partnerships

Flow Chemistry Approaches for Poorly Soluble Pharmaceutical Intermediates

Advanced Strategies for Handling Unstable Intermediates with Flow Chemistry

Electrochemical cell design: Turning electron transfer into a practical synthetic tool

Semi-targeted integration in cell line development supports stable clone selection and more predictable biologics development.

From Faster CLD to Smarter CMC Decisions: How Semi-Targeted Integration Changes the Biologics Game